Guided Therapeutics, Inc. (GTHP)
OTCMKTS
· Delayed Price · Currency is USD
0.262
-0.038 (-12.67%)
Mar 9, 2026, 2:43 PM EST
Guided Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 0.09 | 0.39 | 0.59 | 2.31 | 0.64 | 0.18 | Upgrade
|
| Cash & Short-Term Investments | 0.09 | 0.39 | 0.59 | 2.31 | 0.64 | 0.18 | Upgrade
|
| Cash Growth | -55.16% | -34.35% | -74.45% | 259.72% | 253.30% | -79.75% | Upgrade
|
| Receivables | 0.01 | 0 | 0.01 | 0.01 | 0.05 | 0.02 | Upgrade
|
| Inventory | 0.58 | 0.63 | 0.63 | 0.55 | 0.57 | 0.61 | Upgrade
|
| Other Current Assets | 0.12 | 0.17 | 0.16 | 0.14 | 0.38 | 0.09 | Upgrade
|
| Total Current Assets | 0.8 | 1.2 | 1.39 | 3 | 1.64 | 0.9 | Upgrade
|
| Property, Plant & Equipment | 0.09 | 0.16 | 0.26 | 0.35 | 0.39 | 0.45 | Upgrade
|
| Other Long-Term Assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | - | Upgrade
|
| Total Assets | 0.9 | 1.38 | 1.67 | 3.37 | 2.04 | 1.35 | Upgrade
|
| Accounts Payable | 2.41 | 2.13 | 2.02 | 2.23 | 2.45 | 2.54 | Upgrade
|
| Accrued Expenses | 0.78 | 0.78 | 0.84 | 0.98 | 1.07 | 2.79 | Upgrade
|
| Short-Term Debt | 1.22 | 0.14 | 0.06 | 0.06 | 0.82 | 1.05 | Upgrade
|
| Current Portion of Long-Term Debt | 1.04 | 1.8 | 1.14 | 0.75 | 0.25 | 2.29 | Upgrade
|
| Current Portion of Leases | 0.08 | 0.11 | 0.09 | 0.08 | 0.07 | 0.06 | Upgrade
|
| Current Unearned Revenue | 0.69 | 0.85 | 0.42 | 0.51 | 0.34 | 0.04 | Upgrade
|
| Other Current Liabilities | 0.25 | 0.35 | 0.23 | 0.27 | 0.7 | 0.2 | Upgrade
|
| Total Current Liabilities | 6.47 | 6.16 | 4.81 | 4.87 | 5.69 | 8.96 | Upgrade
|
| Long-Term Debt | 0.08 | 0.06 | 0.51 | 1.13 | 1.43 | 0.62 | Upgrade
|
| Long-Term Leases | - | 0.05 | 0.16 | 0.25 | 0.33 | 0.39 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.01 | 0.03 | 2.23 | Upgrade
|
| Total Liabilities | 6.55 | 6.27 | 5.48 | 6.25 | 7.49 | 12.21 | Upgrade
|
| Common Stock | 3.47 | 3.45 | 3.44 | 3.44 | 3.4 | 3.4 | Upgrade
|
| Additional Paid-In Capital | 145.21 | 142.5 | 140.98 | 138.09 | 126.8 | 123.11 | Upgrade
|
| Retained Earnings | -155.81 | -153.71 | -151.12 | -147.36 | -142.39 | -139.96 | Upgrade
|
| Treasury Stock | -0.13 | -0.13 | -0.13 | -0.13 | -0.13 | -0.13 | Upgrade
|
| Total Common Equity | -7.26 | -7.89 | -6.83 | -5.96 | -12.32 | -13.58 | Upgrade
|
| Shareholders' Equity | -5.65 | -4.89 | -3.81 | -2.88 | -5.45 | -10.86 | Upgrade
|
| Total Liabilities & Equity | 0.9 | 1.38 | 1.67 | 3.37 | 2.04 | 1.35 | Upgrade
|
| Total Debt | 2.42 | 2.16 | 1.96 | 2.26 | 2.9 | 4.41 | Upgrade
|
| Net Cash (Debt) | -2.33 | -1.77 | -1.37 | 0.05 | -2.26 | -4.22 | Upgrade
|
| Net Cash Per Share | -0.03 | -0.03 | -0.03 | 0.00 | -0.17 | -0.39 | Upgrade
|
| Filing Date Shares Outstanding | 83.6 | 77.97 | 55.61 | 50.51 | 22.06 | 13.18 | Upgrade
|
| Total Common Shares Outstanding | 83.6 | 65.13 | 54.11 | 48.6 | 13.67 | 13.14 | Upgrade
|
| Working Capital | -5.67 | -4.96 | -3.42 | -1.87 | -4.06 | -8.07 | Upgrade
|
| Book Value Per Share | -0.09 | -0.12 | -0.13 | -0.12 | -0.90 | -1.03 | Upgrade
|
| Tangible Book Value | -7.26 | -7.89 | -6.83 | -5.96 | -12.32 | -13.58 | Upgrade
|
| Tangible Book Value Per Share | -0.09 | -0.12 | -0.13 | -0.12 | -0.90 | -1.03 | Upgrade
|
| Machinery | 0.97 | 0.97 | 0.97 | 1.12 | 1.09 | 1.08 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.01 | - | Upgrade
|
| Leasehold Improvements | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.